Thérapie génique conduisant à l'inactivation de CCR5 - Vers l'éradication du VIH?

In the event of a large use of genetic therapies during HIV infection, beside the context of HSCT, it will be necessary to target several cellular factors in order to obtain a long term control of HIV as observed in the Berlin patient.